D. E. Shaw & Co., Inc. - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q1 2022$42,000
-99.1%
10,273
-97.0%
0.00%
-100.0%
Q4 2021$4,475,000
-68.6%
347,911
-73.6%
0.00%
-69.2%
Q3 2021$14,253,000
+24.4%
1,319,793
+5.2%
0.01%
+30.0%
Q2 2021$11,456,000
+125.0%
1,254,720
+132.4%
0.01%
+100.0%
Q1 2021$5,091,000
+526.2%
539,798
+161.6%
0.01%
+400.0%
Q4 2020$813,000
+71.2%
206,362
+15.2%
0.00%
Q3 2020$475,000
+202.5%
179,167
+1668.7%
0.00%
Q4 2018$157,00010,1300.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$17,536,0001.82%
EcoR1 Capital, LLC 3,421,287$13,480,0000.72%
FRAZIER MANAGEMENT LLC 2,061,758$8,123,0000.63%
BVF INC/IL 2,695,418$10,620,0000.42%
Column Group LLC 869,493$3,426,0000.31%
Avidity Partners Management LP 2,122,064$8,361,0000.27%
Redmile Group, LLC 3,059,794$12,056,0000.15%
SkyOak Wealth, LLC 69,778$275,0000.09%
Tekla Capital Management LLC 419,005$1,651,0000.06%
Blackstone Inc. 2,567,445$10,116,0000.04%
View complete list of GRITSTONE ONCOLOGY INC shareholders